GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.72 $2.31 Thursday, 18th Apr 2024 CTMX stock ended at $1.73. This is 1.70% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.92% from a day low at $1.72 to a day high of $1.79.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
2023-11-22 $1.31 $1.31 $1.22 $1.29 98 217
2023-11-21 $1.38 $1.38 $1.29 $1.31 134 347
2023-11-20 $1.35 $1.40 $1.32 $1.39 188 348
2023-11-17 $1.28 $1.33 $1.27 $1.32 131 903
2023-11-16 $1.30 $1.31 $1.26 $1.29 96 491
2023-11-15 $1.30 $1.33 $1.28 $1.29 277 643
2023-11-14 $1.26 $1.31 $1.24 $1.28 234 592
2023-11-13 $1.18 $1.23 $1.17 $1.23 145 454
2023-11-10 $1.18 $1.20 $1.16 $1.17 96 679
2023-11-09 $1.25 $1.27 $1.16 $1.20 204 791
2023-11-08 $1.29 $1.32 $1.25 $1.25 314 793
2023-11-07 $1.28 $1.32 $1.27 $1.28 152 466
2023-11-06 $1.27 $1.30 $1.23 $1.27 164 973
2023-11-03 $1.18 $1.30 $1.18 $1.26 238 419
2023-11-02 $1.09 $1.19 $1.09 $1.17 198 049
2023-11-01 $1.09 $1.12 $1.05 $1.08 158 849
2023-10-31 $1.09 $1.13 $1.07 $1.10 73 270
2023-10-30 $1.10 $1.14 $1.04 $1.11 269 226
2023-10-27 $1.15 $1.15 $1.04 $1.07 296 945
2023-10-26 $1.16 $1.21 $1.10 $1.13 262 565
2023-10-25 $1.22 $1.25 $1.17 $1.17 321 877
2023-10-24 $1.30 $1.31 $1.23 $1.27 164 600
2023-10-23 $1.35 $1.38 $1.23 $1.28 187 455
2023-10-20 $1.38 $1.44 $1.33 $1.33 363 565
2023-10-19 $1.35 $1.41 $1.31 $1.34 210 869
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT